Search

Your search keyword '"Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness [DISEASES]"' showing total 3 results
Start Over Descriptor "Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness [DISEASES]" Topic virosis::infecciones por virus arn::infecciones por nidovirales::infecciones por coronaviridae::infecciones por coronavirus [enfermedades]
3 results on '"Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness [DISEASES]"'

1. 'Acute kidney injury in critically ill patients with COVID–19: The AKICOV multicenter study in Catalonia'

Author

de la Vega Sánchez, Arsenio, Navas Pérez, Ana Maria, Pérez Carrasco, Marcos, Torrens Sonet, María, Diaz Buendia, Yolanda, Ortiz Ballujera, Patricia, Institut Català de la Salut, [Sánchez AV, Pérez-Carrasco M] Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació (SODIR), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Pérez AN] Critical Care Center, Parc Tauli Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain. [Sonet MT] Intensive Care Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Buendia YD] Critical Care Department, Hospital del Mar, Barcelona, Spain. [Ballujera PO] Intensive Care Department, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain, and Vall d'Hebron Barcelona Hospital Campus

Subjects
afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedad crítica [ENFERMEDADES], Insuficiència renal aguda - Prognosi, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal::lesión renal aguda [ENFERMEDADES], virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Ronyons - Malalties - Prognosi, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Acute Kidney Injury [DISEASES], Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness [DISEASES], COVID-19 (Malaltia) - Complicacions
Abstract

Acute kidney injury; COVID-19; Catalonia Lesión renal aguda; COVID-19; Cataluña Lesió renal aguda; COVID-19; Catalunya This study describes the incidence, evolution and prognosis of acute kidney injury (AKI) in critical COVID-19 during the first pandemic wave. We performed a prospective, observational, multicenter study of confirmed COVID-19 patients admitted to 19 intensive care units (ICUs) in Catalonia (Spain). Data regarding demographics, comorbidities, drug and medical treatment, physiological and laboratory results, AKI development, need for renal replacement therapy (RRT) and clinical outcomes were collected. Descriptive statistics and logistic regression analysis for AKI development and mortality were used. A total of 1,642 patients were enrolled (mean age 63 (15.95) years, 67.5% male). Mechanical ventilation (MV) was required for 80.8% and 64.4% of these patients, who were in prone position, while 67.7% received vasopressors. AKI at ICU admission was 28.4% and increased to 40.1% during ICU stay. A total of 172 (10.9%) patients required RRT, which represents 27.8% of the patients who developed AKI. AKI was more frequent in severe acute respiratory distress syndrome (ARDS) ARDS patients (68% vs 53.6%, p

Published
2023

2. Pre-analytical and analytical procedures to avoid loss of vitamin C. Comment on: 'COVID-19: up to 82% critically ill patients had low vitamin C values'

Author

Luis Chiscano-Camón, Juan Carlos Ruiz-Rodriguez, Roser Ferrer, Sílvia Camós, Adolf Ruiz-Sanmartin, Ricard Ferrer, Institut Català de la Salut, [Chiscano-Camón L, Ruiz-Rodriguez JC, Ruiz-Sanmartin A, Ferrer R] Unitat de Cures Intensives, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ferrer R, Camós S] Servei de Bioquímica, Laboratoris Clínics, Vall d’Hebron Hospital Universitari, Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus

Subjects
Vitamina C, Nutrition and Dietetics, compuestos orgánicos::ácidos carboxílicos::ácidos acíclicos::azúcares ácidos::ácido ascórbico [COMPUESTOS QUÍMICOS Y DROGAS], afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedad crítica [ENFERMEDADES], virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Medicine (miscellaneous), Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], COVID-19 (Malaltia), Unitats de cures intensives, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness [DISEASES], Organic Chemicals::Carboxylic Acids::Acids, Acyclic::Sugar Acids::Ascorbic Acid [CHEMICALS AND DRUGS]
Abstract

COVID-19; Vitamin C COVID-19; Vitamina C COVID-19; Vitamina C

Published
2022

3. Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study

Author

Buetti, Niccolò, Tabah, Alexis, Loiodice, Ambre, Ruckly, Stéphane, Aslan, Abdullah Tarik, Montrucchio, Giorgia, Cortegiani, Andrea, Saltoglu, Nese, Kayaaslan, Bircan, Aksoy, Firdevs, Murat, Akova, Akdoğan, Özlem, Saracoglu, Kemal Tolga, Erdogan, Cem, Leone, Marc, Ferrer, Ricard, Paiva, José-Artur, Hayashi, Yoshiro, Ramanan, Mahesh, Conway Morris, Andrew, Barbier, François, Timsit, Jean-François, Lipman, Jeffrey, Litton, Edward, Palermo, Anna Maria, Yap, Timothy, Eroglu, Ege, Hosokawa, Koji, Yoshida, Hideki, Fujitani, Shigeki, Zand, Farid, Mahmoodpoor, Ata, Tabatabaei, Seyed Mohammad Nasirodin, Elrabi, Omar, Almekhlafi, Ghaleb A, Vidal, Gabriela, Aparicio, Marta, Alonzo, Irene, Namendys-Silva, Silvio A, Hermosillo, Mariana, Castillo, Roberto Alejandro, De Bus, Liesbet, De Waele, Jan, Hollevoet, Isabelle, De Schryver, Nicolas, Serck, Nicolas, Kovacevic, Pedja, Zlojutro, Biljana, Ruppe, Etienne, Montravers, Philippe, Dulac, Thierry, Castanera, Jérémy, Massri, Alexandre, Guesdon, Charlotte, Garcon, Pierre, Duprey, Matthieu, Philippart, François, Tran, Marc, Bruel, Cédric, Kalfon, Pierre, Badre, Gaëtan, Demeret, Sophie, Le Guennec, Loïc, Bassetti, Matteo, Giacobbe, Daniele, Sales, Gabriele, Daroui, Ivan, Lodi, Giovanni, Ippolito, Mariachiara, Bellina, Davide, Di Guardo, Andrea, Rocco, Monica, Fiorelli, Silvia, Mikstacki, Adam, Peichota, Mariusz, Pietraszek-Grzywaczewska, Iwona, Póvoa, Pedro, Krystopchuk, Andriy, Teresa, Ana, De Figueiredo, António Manuel Pereira, Botelho, Isabel, Costa, Vasco, Cunha, Rui Pedro, Gritsan, Alexey, Belskiy, Vladislav, Furman, Mikhail, Martinez, Maria, Casares, Vanessa, Arnillas, Maria Pilar Gracia, Bermudez, Rosana Munoz, Ubeda, Alejandro, Salgado, Maria, Maseda, Emilio, De La Rica, Alejandro Suarez, Blasco-Navalpotro, Miguel Angel, Gallego, Alberto Orejas, Prazak, Josef, Pagani, JL, Abed-Maillard, S, Iskit, Arzu Topeli, Mehtap, Selcuk, Ceyhun, Solakoğlu, Kalem, Ayşe Kaya, Kurt, Ibrahim, Telli, Murat, Ozturk, Barcin, Baykam, Nurcan, Karaali, Ridvan, Koksal, Iftihar, Bilir, Yeliz, Guzeldag, Seda, Ersoz, Gulden, Evik, Guliz, Bayindir, Yasar, Ersoy, Yasemin, Ercole, Ari, Raj, Ashok, Zormpa, Artemis, Tinaslanidis, George, Khade, Reena, Roshdy, Ashraf, Kannan, Santhana, Antrolikar, Supriya, Marsden, Nicholas, Attwood, Ben, Patel, Jamie, Gurjar, Mohan, Dsilva, Carol, Chandran, Jagadish, Sanousi, Bashir El, Saidahmed, Elfayadh, Hamid, Hytham KS, Buetti, Niccolò, Tabah, Alexi, Loiodice, Ambre, Ruckly, Stéphane, Aslan, Abdullah Tarik, Montrucchio, Giorgia, Cortegiani, Andrea, Saltoglu, Nese, Kayaaslan, Bircan, Aksoy, Firdev, Murat, Akova, Akdoğan, Özlem, Saracoglu, Kemal Tolga, Erdogan, Cem, Leone, Marc, Ferrer, Ricard, Paiva, José-Artur, Hayashi, Yoshiro, Ramanan, Mahesh, Conway Morris, Andrew, Barbier, Françoi, Timsit, Jean-François, Conway Morris, Andrew [0000-0002-3211-3216], Apollo - University of Cambridge Repository, Institut Català de la Salut, [Buetti N] Infection Control Program and WHO Collaborating Centre on Patient Safety, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. INSERM, IAME, Université Paris-Cité, Paris, France. [Tabah A] Intensive Care Unit, Redclife Hospital, Metro North Hospital and Health Services, Brisbane, QLD, Australia. Queensland University of Technology, Brisbane, QLD, Australia. Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. [Loiodice A, Ruckly S] ICURESEARCH, Fonaine, France. [Aslan AT] Department of Internal Medicine, Hacettepe University, Sihhiye, Ankara, Turkey. [Montrucchio G] Department of Surgical Sciences, University of Turin, Turin, Italy. Department of Anaesthesia, Critical Care and Emergency, Città Della Salute e Della Scienza Hospital, Turin, Italy. [Ferrer R] Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Xoc, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Timsit, Jean-Françoi, Lipman, Jeffrey, Litton, Edward, Palermo, Anna Maria, Yap, Timothy, Eroglu, Ege, Hosokawa, Koji, Yoshida, Hideki, Fujitani, Shigeki, Zand, Farid, Mahmoodpoor, Ata, Tabatabaei, Seyed Mohammad Nasirodin, Elrabi, Omar, Almekhlafi, Ghaleb A., Vidal, Gabriela, Aparicio, Marta, Alonzo, Irene, Namendys-Silva, Silvio A., Hermosillo, Mariana, Castillo, Roberto Alejandro, De Bus, Liesbet, De Waele, Jan, Hollevoet, Isabelle, De Schryver, Nicola, Serck, Nicola, Kovacevic, Pedja, Zlojutro, Biljana, Ruppe, Etienne, Montravers, Philippe, Dulac, Thierry, Castanera, Jérémy, Massri, Alexandre, Guesdon, Charlotte, Garcon, Pierre, Duprey, Matthieu, Philippart, Françoi, Tran, Marc, Bruel, Cédric, Kalfon, Pierre, Badre, Gaëtan, Demeret, Sophie, Le Guennec, Loïc, Bassetti, Matteo, Giacobbe, Daniele, Sales, Gabriele, Daroui, Ivan, Lodi, Giovanni, Ippolito, Mariachiara, Bellina, Davide, Di Guardo, Andrea, Rocco, Monica, Fiorelli, Silvia, Mikstacki, Adam, Peichota, Mariusz, Pietraszek-Grzywaczewska, Iwona, Póvoa, Pedro, Krystopchuk, Andriy, Teresa, Ana, de Figueiredo, António Manuel Pereira, Botelho, Isabel, Costa, Vasco, Cunha, Rui Pedro, Gritsan, Alexey, Belskiy, Vladislav, Furman, Mikhail, Martinez, Maria, Casares, Vanessa, Arnillas, Maria Pilar Gracia, Bermudez, Rosana Munoz, Ubeda, Alejandro, Salgado, Maria, Maseda, Emilio, De La Rica, Alejandro Suarez, Blasco-Navalpotro, Miguel Angel, Gallego, Alberto Oreja, Prazak, Josef, Pagani, J. L., Abed-Maillard, S., Iskit, Arzu Topeli, Mehtap, Selcuk, Ceyhun, Solakoğlu, Kalem, Ayşe Kaya, Kurt, Ibrahim, Telli, Murat, Ozturk, Barcin, Baykam, Nurcan, Karaali, Ridvan, Koksal, Iftihar, Bilir, Yeliz, Guzeldag, Seda, Ersoz, Gulden, Evik, Guliz, Bayindir, Yasar, Ersoy, Yasemin, Ercole, Ari, Raj, Ashok, Zormpa, Artemi, Tinaslanidis, George, Khade, Reena, Roshdy, Ashraf, Kannan, Santhana, Antrolikar, Supriya, Marsden, Nichola, Attwood, Ben, Patel, Jamie, Gurjar, Mohan, Dsilva, Carol, Chandran, Jagadish, Sanousi, Bashir El, Saidahmed, Elfayadh, and Hamid, Hytham K. S.

Subjects
Male, bloodstream infections, Other subheadings::Other subheadings::/epidemiology [Other subheadings], Critical Illness, COVID-19 (Malaltia) - Epidemiologia, RESISTANT ENTEROCOCCI, Bacteremia, Bloodstream infection, Critical Care and Intensive Care Medicine, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness [DISEASES], Cohort Studies, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedad crítica [ENFERMEDADES], Sepsis, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Medicine and Health Sciences, Humans, NCT03937245, Unitats de cures intensives, Aged, Cross Infection, Malalties bacterianes, infecciones bacterianas y micosis::infección::infección hospitalaria [ENFERMEDADES], Research, Otros calificadores::Otros calificadores::/epidemiología [Otros calificadores], COVID-19, Enterococcus, ICU-acquired, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Bacterial Infections and Mycoses::Infection::Cross Infection [DISEASES], Intensive Care Units, NCT, ICU, RNA
Abstract

Funder: European society of Intensive Care Medicine, Funder: European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Funder: Norva Dahlia foundation and the Redcliffe Hospital Private Practice Trust Fund, Background The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients. Methods We used data from the Eurobact II study, a prospective observational multicontinental cohort study on HABSI treated in ICU. For the current analysis, we selected centers that included both COVID-19 and non-COVID-19 critically ill patients. We performed descriptive statistics between COVID-19 and non-COVID-19 in terms of patients’ characteristics, source of infection and microorganism distribution. We studied the association between COVID-19 status and mortality using multivariable fragility Cox models. Results A total of 53 centers from 19 countries over the 5 continents were eligible. Overall, 829 patients (median age 65 years [IQR 55; 74]; male, n = 538 [64.9%]) were treated for a HABSI. Included patients comprised 252 (30.4%) COVID-19 and 577 (69.6%) non-COVID-19 patients. The time interval between hospital admission and HABSI was similar between both groups. Respiratory sources (40.1 vs. 26.0%, p < 0.0001) and primary HABSI (25.4% vs. 17.2%, p = 0.006) were more frequent in COVID-19 patients. COVID-19 patients had more often enterococcal (20.5% vs. 9%) and Acinetobacter spp. (18.8% vs. 13.6%) HABSIs. Bacteremic COVID-19 patients had an increased mortality hazard ratio (HR) versus non-COVID-19 patients (HR 1.91, 95% CI 1.49–2.45). Conclusions We showed that the epidemiology of HABSI differed between COVID-19 and non-COVID-19 patients. Enterococcal HABSI predominated in COVID-19 patients. COVID-19 patients with HABSI had elevated risk of mortality. Trial registration ClinicalTrials.org number NCT03937245. Registered 3 May 2019.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results